Skip to main content

Perceptive Advisors LLC

SEC CIK
0001224962
Latest filing
Aug 14, 2026

Holdings in Q2 2022

Holdings as of Jun 30, 2022, filed Aug 15, 2022. Long positions only; changes compare share counts with Q1 2022.

Institution overview
Positions
109
−26 vs. Q1 2022
Portfolio value
$3.18B
−$1.63B (−33.9%) vs. Q1 2022
Filed
Aug 15, 2022
SEC
Holdings of Perceptive Advisors LLC in Q2 2022
SecurityClassSharesValue% of portfolioShare changeActionHistory
SWTXSpringWorks Therapeutics, Inc.COM3,867,446$95.2M3.0%−660,547−14.6%ReducedHistory
GBTGlobal Blood Therapeutics, Inc.COM3,015,054$96.3M3.0%−877,439−22.5%ReducedHistory
CRNXCrinetics Pharmaceuticals, Inc.COM5,321,032$99.2M3.1%+157,515+3.1%AddedHistory
LIANYLianBioSPONSORED ADS56,560,211$122.2M3.8%+240,251+0.4%AddedHistory
IOVAIovance Biotherapeutics, Inc.COM11,826,299$130.6M4.1%−374,962−3.1%ReducedHistory
CERECerevel Therapeutics Holdings, Inc.COM5,086,727$134.5M4.2%00.0%UnchangedHistory
MRTXMirati Therapeutics, Inc.COM2,866,863$192.5M6.0%+486,153+20.4%AddedHistory
FOLDAmicus Therapeutics, Inc.COM26,895,532$288.9M9.1%−660,313−2.4%ReducedHistory
Travere Therapeutics, Inc.89422GAA5NOTE 2.250% 3/0–$455.9M14.3%–––

Options (2)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Perceptive Advisors LLC in Q2 2022
SecurityClassPutsCalls
State Street SPDR S&P Biotech ETF78464A870ETF$7.43M–
FLNAFilana Therapeutics, Inc.COM$2.81M–

Sold out since Q1 2022 (33)

Positions held at the end of Q1 2022 that are gone from this filing.

Positions of Perceptive Advisors LLC sold out since Q1 2022
SecurityClassShares in Q1 2022Value in Q1 2022% of portfolio in Q1 2022History
HZNPHorizon Therapeutics Public Ltd CoSHS1,357,903$142.9M3.0%History
Collegium Pharmaceutical, Inc19459JAA2NOTE 2.625% 2/1–$89.5M1.9%–
NVRONevro CorpCOM477,037$34.5M0.7%History
PENPenumbra IncCOM143,591$31.9M0.7%History
ZNTLZentalis Pharmaceuticals, Inc.COM501,509$23.1M0.5%History
LEGNLegend Biotech CorpSPONSORED ADS616,141$22.4M0.5%History
AXNXAxonics, Inc.COM341,211$21.4M0.4%History
LUNGPulmonx CorpCOM537,779$13.3M0.3%History
RCUSArcus Biosciences, Inc.COM405,000$12.8M0.3%History
Nanostring Technologies Inc63009RAD1NOTE 2.625% 5/0–$11.0M0.2%–
HLTHCue Health Inc.COM1,580,607$10.2M0.2%History
BCLS Acquisition CorpG0904B105COM CL A1,000,000$9.87M0.2%–
Summit Healthcre Acquistn CoG8566R128UNIT 06/03/20261,000,000$9.78M0.2%–
RACBResearch Alliance Corp. IICOM CL A1,000,000$9.76M0.2%History
EVHEvolent Health, Inc.CL A250,000$8.07M0.2%History
ACADAcadia Pharmaceuticals IncCOM284,853$6.90M0.1%History
ACCDAccolade, Inc.COM330,682$5.81M0.1%History
MRUSMerus N.V.COM209,046$5.53M0.1%History
DALSDA32 Life Science Tech Acquisition Corp.CLASS A COM500,000$4.86M0.1%History
SGHTSight Sciences, Inc.COM390,000$4.51M0.1%History
OBIOOrchestra BioMed Holdings, Inc.ORD SHS450,000$4.46M0.1%History
NVTAInvitae CorpCOM554,585$4.42M0.1%History
IMRXImmuneering CorpCLASS A COM681,051$4.41M0.1%History
NARIInari Medical, Inc.Stock30,000$2.72M0.1%History
PRTAProthena Corp Public Ltd CoSHS65,144$2.38M<0.1%History
LENZLENZ Therapeutics, Inc.COM325,854$1.66M<0.1%History
RETAReata Pharmaceuticals IncCL A44,475$1.46M<0.1%History
ONCROncorus, Inc.COM752,241$1.34M<0.1%History
RPIDRapid Micro Biosystems, Inc.CLASS A COM190,745$1.29M<0.1%History
Rockley Photonics Holdings LG7614L117*W EXP 08/11/202500,000$425.0K<0.1%–
Butterfly Network, Inc.124155110*W EXP 05/27/202233,333$238.0K<0.1%–
SLGCWSomaLogic, Inc.*W EXP 03/01/202110,000$235.0K<0.1%History
UTRSMinerva Surgical IncCOM50,268$226.0K<0.1%History